Drug Approvals

Market Analysis: FDA Approval Revnasiran and Hereditary ATTR Amyloidosis

FDA · hereditary ATTR amyloidosis · 4 min

FDA Breakthrough Therapy Designations: Impact on Neurological Disorder Investments 2026

FDA · neurological disorders · 11 min

FDA Accelerated Approval Oncology 2026: Market Analysis & Future Trends

FDA · oncology · 8 min

FDA Approval of Elarekibart: What You Need to Know

FDA · Hereditary ATTR Amyloidosis · 8 min

FDA Approval KRAS G12C NSCLC: Sotorasib & Adagrasib Insights

FDA · oncology · 10 min

FDA Approval mRNA Vaccine RSV: Market Impact & Future Outlook

FDA · Infectious Diseases · 4 min

Frankfurt Court Upholds BESREMi Arbitral Award Favoring AOP Health Over PharmaEssentia

2 min

FDA Approval VX-009: Market Analysis of Oncodex's Oncolytic Virus Therapy

FDA · Oncology · 9 min

FDA Approval ResVax: Comprehensive Market Analysis of Novel mRNA RSV Vaccine

FDA · Respiratory Syncytial Virus (RSV) prevention · 8 min

SAHPRA Biosimilars Approval: Pathway Analysis & Impact on Affordable Medicines

SAHPRA · biosimilars · 11 min

COFEPRIS Drug Approvals 2026: Key Trends and Healthcare Implications

COFEPRIS · 10 min

Cipla Receives FDA Approval for First Generic Ventolin HFA (Albuterol Sulfate) - AB-Rated Therapeutic Equivalent

FDA · 2 min